Supplementary Figure 7: Second iteration of REVEALER for the drug sensitivity to a MEK-inhibitor example.
From: Characterizing genomic alterations in cancer by complementary functional associations
A) Conditional to the summary feature after the first iteration, consisting of BRAF mutation, REVEALER finds KRAS mutations as the top hit. B) The clustered version of the same top scoring features shown in A.
